Matinas BioPharma (MTNB)

• Market cap: $4.36M
• 1 day: -5.15%
• 5 days: -2.27%
• 1 month: 28.36%
• 3 months: 2.38%
• 6 months: -49.61%
• Year to date: 4.03%
• 1 year: -8.9%
• 5 years: -98.37%
• 10 years: -99.66%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Employees: 2